Intermittent versus continuous alkaline therapy for uric acid stones and ureteral stones of uncertain composition

Urology

Volumn 60, Issue 3, 2002, Pages 378-382

  Rodman, John S ^a,b,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c MD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; ALLOPURINOL; ANTIDIARRHEAL AGENT; BICARBONATE; CALCIUM OXALATE; CHOLINESTERASE INHIBITOR; CITRATE POTASSIUM; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCHLORIC ACID; POTASSIUM DERIVATIVE; PROBENECID; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SODIUM DERIVATIVE; URIC ACID; URICOSURIC AGENT;

ALKALOSIS; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DIET THERAPY; DISEASE COURSE; DISEASE SEVERITY; DISORIENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; ESOPHAGITIS; GASTRITIS; HUMAN; HYPOKALEMIA; ILEOSTOMY; IMAGING SYSTEM; KETOACIDOSIS; LEUKEMIA; LITHOTRIPSY; LYMPHOMA; MICTURITION DISORDER; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; STONE FORMATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME; URETER STENT; URETER STONE; URIC ACID STONE; URIC ACID URINE LEVEL; URINE PH; WEIGHT REDUCTION; X RAY;

CITRATES; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYDROGEN-ION CONCENTRATION; POTASSIUM CITRATE; SODIUM BICARBONATE; URETERAL CALCULI; URIC ACID; URINARY CALCULI;

EID: 0036753751     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01725-9     Document Type: Review

References (17)

1. Rodman J.S., Williams J.J., Peterson C.M. Dissolution of uric acid calculi. J Urol. 131:1984;1039-1044.
2. Rodman J.S. Prophylaxis of uric acid stones with alternate day doses of alkaline potassium salts. J Urol. 145:1991;97-99.
3. Rodman J.S., Sosa R.E., Lopez M.A. Diagnosis and treatment of uric acid calculi. Coe F.L., Favus M.J., Pak C.Y.C., et al. Kidney Stones Medical and Surgical Management . 1996;973 Lippincott-Raven, Philadelphia.
4. Riese R.J., Sakhaee K. Uric acid nephrolithiasis pathogenesis and treatment . J Urol. 148:1992;765-771.
5. Coe F.L. Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 24:1983;392-403.
6. Gutman A.B., Yu T.F. Uric acid nephrolithiasis. Am J Med. 45:1965;756-779.
7. Strohmaier W.L., Weigl A. Is undue acidity of urine in uric acid stone formers caused by a decreased excretion of ammonia? Rodgers A.L., Hibbert B.E., Hess B., et al. Urolithiasis 2000. 2000;596-597 University of Cape Town, Cape Town.
8. Yu T.F., Gutman A.B. Uric acid nephrolithiasis in gout predisposing factors . Ann Intern Med. 67:1967;1133-1148.
9. Rodman J.S. Management of uric acid calculi in the elderly patient. Geriatric Nephrol Urol. 1:1991;129-137.
10. Pak C.Y.C., Waters O., Arnold L., et al. Mechanisms for urolithiasis among patients with hyperuricosuria supersaturation of urine with respect to monosodium urate . J Clin Invest. 59:1977;426-431.
11. Coe F.L., Lawton R.L., Goldstein R.B. Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exper Biol Med. 149:1975;926-932.
12. Sakhaee K., Nicar M., Hill K., et al. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int. 24:1983;348-352.
13. Johnson A.L., Taylor D.W., Sackett D.L., et al. Self-recording of blood pressure in the management of hypertension. Can Med Assoc J. 119:1978;1034-1039.
14. Low R.K., Stoller M.L. Uric acid related nephrolithiasis. Urol Clin North Am. 24:1997;135-148.
15. Clayman R.V., McDougall E.M., Nakada S.V. Endourology of the upper urinary tract percutaneous renal and ureteral procedures . Walsh P.C., Retik A.B., Vaughan E.D. Jr, et al. Campbell's Urology. 1998;2789 WB Saunders, Philadelphia.
16. Kok D.J., Papapoulos S.E., Bijvoet O.L.M. Excessive crystal agglomeration with low citrate excretion in recurrent stone formers. Lancet. 1:1986;1056-1058.
17. Cicerello E., Merlo F., Maccatrozzo L., et al. Effect of potassium citrate therapy on clearance of residual fragments after ESWL in calcium nephrolithiasis patients. Rodgers A.L., Hibbert B.E., Hess B., et al. Urolithiasis 2000. 2000;592-593 University of Cape Town, Cape Town.